尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Richards C Marc, 首席财务官. Officer active across 2 companies, notably MEDNAX, INC.. Cumulatively, 5 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €301k. Activity tracked since 1 March 2022. The latest transaction was disclosed on 9 August 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Richards C Marc is Director Executive, Chief Financial Officer. He has 5 filings in total, and across the 5 recent filings we hold, the transactions span 2022-03-03 to 2024-08-13, with EUR 300690 in sales and EUR 0 in purchases. The companies named are Pediatrix Medical Group, Inc. and MEDNAX, INC., and the modal transaction nature is Attribution.